Previous Page  25 / 31 Next Page
Information
Show Menu
Previous Page 25 / 31 Next Page
Page Background

Volume 3, Issue 4 (Suppl)

Polym Sci

ISSN: 2471-9935 Polym Sci, an open access journal

October 12-13, 2017 Osaka, Japan

Annual Meeting on

Biopolymers and Drug Delivery Systems

Biopolymers Meeting 2017

October 12-13 2017

Page 66

Polym Sci 2017, 3:4

DOI: 10.4172/2471-9935-C1-006

Design, formulation and evaluation of transdermal patch of Propranolol using chamomile essential oil as

permeation enhancer:

In vitro in vivo

chapter

Muhammad Akhlaq

1

, Muhammad Imran

1

and Muhammad Zeeshan Danish

2

1

Gomal University, Pakistan

2

University of Punjab, Pakistan

Statement of the Problem:

Skin permeation enhancement technology is a rapidly emerging field which would expressively increase

the number of drugs which is suitable for transdermal drug delivery. Transdermal drug administration route offers many benefits over

oral administration of drugs and has stimulated research to find ways to overcome the barrier function of the skin by use of various

enhancers’ approaches. The exploration for the ideal skin penetration enhancer has been the emphasis of significant research effort

over a number of eras. Many potent enhancers have been revealed, but in most of the cases, their effects are associated with toxicity.

Methodology:

Physiochemical evaluations like majorly, drug content and aging, moisture uptake and thickness were performed

to rationalize the suitability and pertinence of the formulation.

In vitro

and

ex vivo

and

in vivo

studies were carried out using Franz

diffusion cell using albino rabbits (pharmacokinetics). In vitro permeation studies demonstrated a significant enhancement with

chamomile essential oil.

Findings:

Formulation with 10% chamomile essential oil exhibited the best permeation of the model drug evidenced by kinetic

parameters. The pharmacokinetic parameters, such as the C

max,

T

max,

MRT, AUCo-t and T1/2 derived from transdermal administration

differed significantly (p<0.05) from those estimated fromoral administration. The C

max

of model drug after transdermal administration

of optimized patch formulation was found to be 88.37±2.3 µg/ml and the plasma concentration was maintained for 36 hours which

was in good agreement with the reported plasma levels of model drug reported in published clinical studies. In variance to oral

delivery well sustained activity was observed over a period of 24 hours after transdermal administration.

Conclusion & Significance:

Taking together, the transdermal patch using indigenous natural chamomile essential oil can be

successively used to achieve better patient compliance in contrast to the oral conventional tablets in pharmaceutical industries.

baddam_sunitha@rediffmail.com